Members

  First name: Sarah
  Last name: Tubiana
  Function: Praticien Hospitalier
  Position: epidemiologist
  Email: sarah.tubiana
._
_.
inserm.fr

Research interest



Education

Degree

PharmD; PhD

Academic positions

PhD student

Exhaustive list of publications

2023


Celestin B, Habensus EI, Tubiana S, Préau M, Millot S, Lescure FX, Kerneis C, Para M, Duval X, Iung B, PIsg
Determinants of adherence to oral hygiene prophylaxis guidelines in patients with previous infective endocarditis.
Archives of Cardiovascular Diseases 2023, S1875-2136(23)00027-X.

Bouzid D, Le Hingrat Q, Salipante F, Ferré V, Chevallier T, Tubiana S, Christophe Lucet J, Choquet C, Yazdanpanah Y, François Timsit J, Descamps D, Houhou N, Visseaux B, Loubet P
Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, S1198-743X(23)00042-3.

Nagle S, Roland-Nicaise P, Klein I, Bendid Y, Tubiana S, Papo T, Duval X, Iung B, Sacré K, ISG
Antiphospholipid Autoantibodies and Brain Ischemic Lesions in Infective Endocarditis.
Thrombosis and Haemostasis 2023

Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, Bui E, Pannier E, Ghosn J, Garrait V, Avettand-Fenoel V, Frange P, Warszawski J, Tubiana R
Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, e590-e598.

Tubiana S, Epelboin L, Casalino E, Naccache JM, Feydy A, Khalil A, Hausfater P, Duval X, Claessens YE, Esg
Effect of diagnosis level of certainty on adherence to antibiotics' guidelines in ED patients with pneumonia: a post-hoc analysis of an interventional trial.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2023, 30, 102-109.

de Villartay JP, Pannier E, Sibiude J, Frange P, Tubiana R, Blanche S
Brief Report: T-Cell Receptor α Repertoire Diversity at Birth After in utero Exposure to HIV Integrase Strand-Transfer Inhibitors.
Journal of Acquired Immune Deficiency Syndromes (1999) 2023, 92, 260-262.

2022


Duval X, Taha MK, Lamaury I, Escaut L, Gueit I, Manchon P, Tubiana S, Hoen B, Csg
One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study.
Advances in Therapy 2022, 39, 3031-3041.

Akroum S, Tubiana S, de Broucker T, Dournon N, Varon E, Ploy MC, Mourvillier B, Oziol E, Lacassin F, Laurichesse H, Hoen B, Duval X, Burdet C, atsg
Long-term neuro-functional disability in adult patients with community-acquired bacterial meningitis.
Infection 2022, 50, 1363-1372.

Béraud G, Tubiana S, Erpelding ML, Le Moing V, Chirouze C, Gorenne I, Manchon P, Tattevin P, Vernet V, Varon E, Hoen B, Duval X, Asg, Csg
Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed?.
Infectious Diseases and Therapy 2022

Belan M, Charmet T, Schaeffer L, Tubiana S, Duval X, Lucet JC, Fontanet A, Birgand G, Kernéis S
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1471-1476.

Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.
Diabetes & Metabolism 2022, 48, 101306.

Breton G, Diallo OH, Cissé M, Diallo OH, Diallo NA, Soumaoro SA, Camara Y, Montoyo A, Rouzioux C, Koita Y, Peytavin G, Tubiana R, Frange P, A1Dsg
HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study.
The Journal of Antimicrobial Chemotherapy 2022, 77, 3093-3101.

Dollfus C, Le Chenadec J, Mandelbrot L, Tubiana R, Faye A, Brossard M, Frange P, Blanche S, Warszawski J, ACsg
Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting.
The Pediatric Infectious Disease Journal 2022, 41, 420-423.

Saint-Lary L, Diallo A, de Monteynard LA, Paul C, Marchand L, Tubiana R, Warszawski J, Mandelbrot L, Rekacewicz C, Petrov-Sanchez V, Faye A, Sibiude J, Dabis F, Sommet A, Leroy V
In utero exposure to antiretroviral drugs and pregnancy outcomes: Analysis of the French ANRS pharmacovigilance database.
British Journal of Clinical Pharmacology 2022, 88, 942-964.

Tubiana S, Sibiude J, Herlemont P, Drouin J, Picone O, Duval X, Weill A, Zureik M, Dray-Spira R
Trends in anti-infective use during pregnancy in France between 2010 and 2019: a nationwide population-based study.
British Journal of Clinical Pharmacology 2022

2021


Benadji A, Duval X, Danis K, Hoen B, Page B, Béraud G, Vernet-Garnier V, Strady C, Brieu N, Maulin L, Roy C, Ploy MC, Gaillat J, Varon E, Tubiana S, CSG, SSG
Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease.
Infection 2021

Crescenzo-Chaigne B, Behillil S, Enouf V, Escriou N, Petres S, Ungeheuer MN, Ghosn J, Tubiana S, Bouadma L, van der Werf S, Demeret C, FCcsg
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients.
Journal of Clinical Virology Plus 2021, 1, 100041.

Tubiana S, Burdet C, Houhou N, Thy M, Manchon P, Blanquart F, Charpentier C, Guedj J, Alavoine L, Behillil S, Leclercq A, Lucet JC, Yazdanpanah Y, Attia M, Demeret C, Rose T, Bielicki JA, Bruijning-Verhagen P, Goossens H, Descamps D, van der Werf S, Lina B, Duval X, Csg, Pi, SI
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort.
The Journal of Infection 2021, 82, 186-230.

Ben Hayoun M, Tubiana S, Varon E, Naccache JM, Le Floch H, Leport C, Claessens YE, Duval X, PEsg
2010 French SPILF-AFSSAPS guiding criteria for Streptococcuspneumoniae acute community-acquired pneumonia: Evaluation in patients of the PACSCAN-ESCAPED cohort.
Infectious Diseases Now 2021, 52, 146-152.

Ferraretto X, Hammas K, Llabador MA, Gricourt S, Labrosse J, Lousqui J, Epelboin S, Tubiana S, Patrat C
Early embryo development anomalies identified by time-lapse system: prevalence and impacting factors.
Reproductive Biomedicine Online 2021, 43, 627-636.

Novelli G, Liu J, Biancolella M, Alonzi T, Novelli A, Patten JJ, Cocciadiferro D, Agolini E, Colona VL, Rizzacasa B, Giannini R, Bigio B, Goletti D, Capobianchi MR, Grelli S, Mann J, McKee TD, Cheng K, Amanat F, Krammer F, Guarracino A, Pepe G, Tomino C, Tandjaoui-Lambiotte Y, Uzunhan Y, Tubiana S, Ghosn J, CHGE, FCCSG, CCC, Notarangelo LD, Su HC, Abel L, Cobat A, Elhanan G, Grzymski JJ, Latini A, Sidhu SS, Jain S, Davey RA, Casanova JL, Wei W, Pandolfi PP
Inhibition of HECT E3 ligases as potential therapy for COVID-19.
Cell Death & Disease 2021, 12, 310.

Duval X, Le Moing V, Tubiana S, Esposito-Farèse M, Ilic-Habensus E, Leclercq F, Bourdon A, Goehringer F, Selton-Suty C, Chevalier E, Boutoille D, Piriou N, Le Tourneau T, Chirouze C, Seronde MF, Morel O, Piroth L, Eicher JC, Humbert O, Revest M, Thébault E, Devillers A, Delahaye F, Boibieux A, Grégoire B, Hoen B, Laouenan C, Iung B, Rouzet F, ATsg
Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, 393-403.

Vulesevic B, Kubota N, Burwash IG, Cimadevilla C, Tubiana S, Duval X, Nguyen V, Arangalage D, Chan KL, Mulvihill EE, Beauchesne L, Messika-Zeitoun D
Size-adjusted aortic valve area: refining the definition of severe aortic stenosis.
European Heart Journal. Cardiovascular Imaging 2021, 22, 1142-1148.

Palich R, Allavena C, Peytavin G, Soulie C, Tubiana R, Weiss L, Montoya Ferrer A, Duvivier C, Bouchaud O, Bottero J, Durand A, Lê MP, Marcelin AG, Dudoit Y, Assoumou L, Katlama C, EQsg
Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen.
The Journal of Antimicrobial Chemotherapy 2021, 76, 477-481.

Palich R, Abdi B, Wirden M, Lourida G, Tubiana R, Faycal A, Valantin MA, Schneider L, Seang S, Agher R, Simon A, Soulie C, Le MP, Peytavin G, Calvez V, Marcelin AG, Katlama C
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients.
The Journal of Antimicrobial Chemotherapy 2021, 76, 1893-1897.

Bouzid D, Casalino E, Mullaert J, Laurent O, Duval X, Lescure FX, Peiffer Smadja N, Tubiana S, Armand Lefèvre L, Descamps D, Fidouh N, Choquet C, Lucet JC, Visseaux B
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.
The Journal of Antimicrobial Chemotherapy 2021, 76, iii20-iii27.

Sibiude J, Le Chenadec J, Mandelbrot L, Dollfus C, Matheron S, Lelong N, Avettand-Fenoel V, Brossard M, Frange P, Reliquet V, Warszawski J, Tubiana R, Esg
Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
AIDS (London, England) 2021, 35, 219-226.

Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, Zhang P, Meertens L, Bolze A, Materna M, Korniotis S, Gervais A, Talouarn E, Bigio B, Seeleuthner Y, Bilguvar K, Zhang Y, Neehus AL, Ogishi M, Pelham SJ, Le Voyer T, Rosain J, Philippot Q, Soler-Palacín P, Colobran R, Martin-Nalda A, Rivière JG, Tandjaoui-Lambiotte Y, Chaïbi K, Shahrooei M, Darazam IA, Olyaei NA, Mansouri D, Hatipoğlu N, Palabiyik F, Ozcelik T, Novelli G, Novelli A, Casari G, Aiuti A, Carrera P, Bondesan S, Barzaghi F, Rovere-Querini P, Tresoldi C, Franco JL, Rojas J, Reyes LF, Bustos IG, Arias AA, Morelle G, Christèle K, Troya J, Planas-Serra L, Schlüter A, Gut M, Pujol A, Allende LM, Rodriguez-Gallego C, Flores C, Cabrera-Marante O, Pleguezuelo DE, de Diego RP, Keles S, Aytekin G, Akcan OM, Bryceson YT, Bergman P, Brodin P, Smole D, Smith CIE, Norlin AC, Campbell TM, Covill LE, Hammarström L, Pan-Hammarström Q, Abolhassani H, Mane S, Marr N, Ata M, Al Ali F, Khan T, Spaan AN, Dalgard CL, Bonfanti P, Biondi A, Tubiana S, Burdet C, Nussbaum R, Kahn-Kirby A, Snow AL, CHGE, CSC, CC, ICG, FCCSG, CCC, AUC, B, NUCSG, Bustamante J, Puel A, Boisson-Dupuis S, Zhang SY, Béziat V, Lifton RP, Bastard P, Notarangelo LD, Abel L, Su HC, Jouanguy E, Amara A, Soumelis V, Cobat A, Zhang Q, Casanova JL
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Science Immunology 2021, 6, eabl4348.

Tubiana S, Labarere J, Levraut J, Michelet P, de Vaux FJ, Doumenc B, Hausfater P, Choquet C, Plaisance P, Schmidt J, Mattei V, Gacia O, Storme D, Ray P, Der Sahakian G, Kouka MC, Jainsky L, Raude J, Duval X, Claessens YE
Effectiveness of a Multifaceted Informational-Based and Text Message Reminders on Pneumococcal and Influenza Vaccinations in Hospital Emergency Departments: A Cluster-Randomized Controlled Trial.
Vaccines 2021, 9, 962.

2020


Loubet P, Tubiana S, Claessens Y, Epelboin L, Ficko C, Le Bel J, Rammaert B, Garin N, Prendki V, Stirnemann J, Leport C, Yazdanpanah Y, Varon E, Duval X, Claessens Y, Duval X, Bouvard E, Carette M, Debray M, Mayaud C, Leport C, Houhou N, Tubiana S, Benjoar M, Blanc F, Brun A, Epelboin L, Ficko C, Khalil A, Lefloch H, Naccache J, Rammaert B, Abry A, Allo J, Andre S, Andreotti C, Baarir N, Bendahou M, Benlafia L, Bernard J, Berthoumieu A, Billemont M, Bokobza J, Brun A, Burggraff E, Canavaggio P, Carette M, Casalino E, Castro S, Choquet C, Clément H, Colosi L, Dabreteau A, Damelincourt S, Dautheville S, Debray M, Delay M, Delerme S, Depierre L, Djamouri F, Dumas F, Fadel M, Feydey A, Freund Y, Garcia L, Goulet H, Hausfater P, Ilic-Habensus E, Josse M, Kansao J, Kieffer Y, Lecomte F, Lemkarane K, Madonna P, Meyniard O, Mzabi L, Pariente D, Pernet J, Perruche F, Piquet J, Ranerison R, Ray P, Renai F, Rouff E, Saget D, Saïdi K, Sauvin G, Trabattoni E, Trimech N, Auger C, Pasquet B, Tamazirt S, Treluyer J, Tubach F, Wang J, Chassany O, Misse C
Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication.
Clinical Microbiology and Infection 2020, 26, 382.e1-382.e7.

Tubiana S, Varon E, Biron C, Ploy MC, Mourvillier B, Taha MK, Revest M, Poyart C, Martin-Blondel G, Lecuit M, Cua E, Pasquet B, Preau M, Hoen B, Duval X, Csg
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 1192-1200.

Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, Duval X, Burdet C, Ichou H, Damond F, Bertine M, Benmalek N, Choquet C, Timsit JF, Ghosn J, Charpentier C, Descamps D, Houhou-Fidouh N, FCcmcCCsg, motFCcsg(ao, motCCsgPi, SC, CCCC, Casa, VL, BC, P, S, G
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, S1198-743X(20)30721-7.

Vulesevic B, Burwash IG, Beauchesne LM, Cimadevilla C, Siouti L, Tubiana S, Duval X, Nguyen V, Arangalage D, Chan KL, Mulvihill EE, Messika-Zeitoun D
Outcomes of Patients With Discordant High-Gradient Aortic Valve Stenosis.
JACC. Cardiovascular imaging 2020, 13, 1636-1638.

Commissaire M, Epelboin S, Vigan M, Tubiana S, Llabador MA, Gauché-Cazalis C, Gricourt S, Ferraretto X, Peigné M
Serum progesterone level and ongoing pregnancy rate following frozen-thawed embryo transfer after artificial endometrial preparation: a monocentric retrospective study.
Journal of Gynecology Obstetrics and Human Reproduction 2020, 101828.

Tubiana S, Launay O, Galtier F, Tattevin P, Postil D, Vanhems P, Lenzi N, Verger P, Duval X
Attitudes, knowledge, and willingness to be vaccinated against seasonal influenza among patients hospitalized with influenza-like-illness: impact of diagnostic testing.
Human Vaccines & Immunotherapeutics 2020, 16, 851-857.

Frange P, Tubiana R, Sibiude J, Canestri A, Arvieux C, Brunet-Cartier C, Cotte L, Reynes J, Mandelbrot L, Warszawski J, Le Chenadec J, AECSG
Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1324-1331.

Palich R, Wirden M, Peytavin G, Lê MP, Seang S, Abdi B, Schneider L, Tubiana R, Valantin MA, Paccoud O, Soulié C, Calvez V, Katlama C, Marcelin AG
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2981-2985.

Tebano G, Soulié C, Schneider L, Blanc C, Agher R, Seang S, Valantin MA, Palich R, Tubiana R, Peytavin G, Marcelin AG, Assoumou L, Katlama C
Long-term follow-up of HIV-infected patients on dolutegravir monotherapy.
The Journal of Antimicrobial Chemotherapy 2020, 75, 675-680.

2019


Hleyhel M, Goujon S, Sibiude J, Tubiana R, Dollfus C, Faye A, Mandelbrot L, Clavel J, Warszawski J, Blanche S, AFPCsG
Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experience.
Environmental and Molecular Mutagenesis 2019, 60, 404-409.

Arangalage D, Mathieu T, Nguyen V, Cimadevilla C, Kerneis C, Duval X, Tubiana S, Hyafil F, Ou P, Tribouilloy C, Vahanian A, Messika-Zeitoun D
Epicardial adipose tissue volume is associated with left ventricular remodelling in calcific aortic valve stenosis.
Archives of Cardiovascular Diseases 2019, 112, 594-603.

Siméon S, Le Moing V, Tubiana S, Duval X, Fournier D, Lavigne JP, Erpelding ML, Gustave CA, Desage S, Chirouze C, Vandenesch F, Tattevin P, VSG
Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25, 481-488.

Duval X, Millot S, Tubiana S, Iung B
[Prevention of Infective endocarditis].
Presse Medicale (Paris, France: 1983) 2019, 48, 556-562.

Vieillard V, Combadière B, Tubiana R, Launay O, Pialoux G, Cotte L, Girard PM, Simon A, Dudoit Y, Reynes J, Rockstroh J, Garcia F, Gatell J, Devidas A, Yazdanpanah Y, Weiss L, Fätkenheuer G, Autran B, Joyeux D, Gharakhanian S, Debré P, Katlama C
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.
NPJ vaccines 2019, 4, 25.

Le Hingrat Q, Collin G, Lê M, Peytavin G, Visseaux B, Bertine M, Tubiana R, Karmochkine M, Valin N, Collin F, Lemaignen A, Bernard L, Damond F, Matheron S, Descamps D, Charpentier C, FNAfRoAaVH(CH2C
A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019, 69, 657-667.

Iung B, Tubiana S, Duval X
Towards an increased awareness on infective endocarditis in patients with bloodstream infections: a role for multivariate scores?.
European Heart Journal 2019, 40, 3245-3247.

Valantin MA, Durand L, Wirden M, Assoumou L, Caby F, Soulié C, Nguyen TTT, Tubiana R, Kirstetter M, Junot H, Marcelin AG, Peytavin G, Tilleul P, Katlama C
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study.
Journal of Antimicrobial Chemotherapy 2019, 74, 2716-2722.

Peyronnet V, Warszawski J, Sibiude J, Dialla O, Bourgeois-Moine A, Bui E, Toulza CS, Peretti D, Brunet-Cartier C, Avettand-Fenoel V, Chenadec JL, Faye A, Tubiana R, Mandelbrot L
Does Changing Antiretroviral Therapy in the First Trimester of Pregnancy for Safety Concerns Have an Impact on Viral Suppression?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2019, 80, 574-584.

Sibiude J, Warszawski J, Tubiana R, Le Chenadec J, Meier F, Faye A, Blanche S, Mandelbrot L, AFPCSG
Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal Cohort.
Journal of Acquired Immune Deficiency Syndromes (1999) 2019, 81, 83-94.

Januel E, Godin O, Moulignier A, Lescure FX, Savatovsky J, Lamirel C, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D, Assoumou L, MBRAK(SG
Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals.
Journal of Acquired Immune Deficiency Syndromes (1999) 2019, 81, 547-551.

Burdet C, Grall N, Linard M, Bridier-Nahmias A, Benhayoun M, Bourabha K, Magnan M, Clermont O, d'Humières C, Tenaillon O, Denamur E, Massias L, Tubiana S, Alavoine L, Andremont A, Mentré F, Duval X, CG
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
Antimicrobial Agents and Chemotherapy 2019, 63, e02244-18.

Cloitre A, Duval X, Tubiana S, Giraud P, Veyrac G, Nosbaum A, Gouraud A, Mahé J, Lesclous P
Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France.
Medicina Oral, Patologia Oral Y Cirugia Bucal 2019, 24, e296-e304.

2018


Kubota N, Testuz A, Boutten A, Robert T, Codogno I, Duval X, Tubiana S, Hekimian G, Arangalage D, Cimadevilla C, Kerneis C, Vahanian A, Messika-Zeitoun D
Impact of Fetuin-A on progression of calcific aortic valve stenosis - The COFRASA - GENERAC study.
International Journal of Cardiology 2018, 265, 52-57.

Moulignier A, Savatovsky J, Assoumou L, Lescure FX, Lamirel C, Godin O, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Abrivard M, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D, MBRaK(SG
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 1762-1769.

Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G, A1H2tSG
First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018

Kerneis C, Pasi N, Arangalage D, Nguyen V, Mathieu T, Verdonk C, Codogno I, Ou P, Duval X, Tubiana S, Cimadevilla C, Vahanian A, Messika-Zeitoun D
Ascending aorta dilatation rates in patients with tricuspid and bicuspid aortic stenosis: the COFRASA/GENERAC study.
European Heart Journal Cardiovascular Imaging 2018, 19, 792-799.

Seang S, Schneider L, Nguyen T, Lê MP, Soulie C, Calin R, Caby F, Valantin MA, Tubiana R, Assoumou L, Marcelin AG, Peytavin G, Katlama C
Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.
The Journal of Antimicrobial Chemotherapy 2018, 73, 490-493.

Storto A, Visseaux B, Bertine M, Le Hingrat Q, Collin G, Damond F, Khuong MA, Blum L, Tubiana R, Karmochkine M, Cazanave C, Matheron S, Descamps D, Charpentier C, AH2CC
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.
The Journal of Antimicrobial Chemotherapy 2018

Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec JL, Marel E, Khoshnood B, Warszawski J, ACEFPCsg
HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
Journal of Acquired Immune Deficiency Syndromes (1999) 2018, 77, 439-450.

Flateau C, Le Bel J, Tubiana S, Blanc FX, Choquet C, Rammaert B, Ray P, Rapp C, Ficko C, Leport C, Claessens YE, Duval X, Esg
High heterogeneity in community-acquired pneumonia inclusion criteria: does this impact on the validity of the results of randomized controlled trials?.
BMC infectious diseases 2018, 18, 607.

2017


Nguyen V, Cimadevilla C, Arangalage D, Dehoux M, Codogno I, Duval X, Tubiana S, Vahanian A, Messika-Zeitoun D
Determinants and prognostic value of B-type natriuretic peptide in patients with aortic valve stenosis.
International Journal of Cardiology 2017, 230, 371-377.

Testuz A, Nguyen V, Mathieu T, Kerneis C, Arangalage D, Kubota N, Codogno I, Tubiana S, Estellat C, Cimadevilla C, Vahanian A, Messika-Zeitoun D
Influence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis.
International Journal of Cardiology 2017, 244, 248-253.

Wirden M, Charpentier C, Tubiana R, Le MP, Desire N, Dionou S, Pichon F, Valantin MA, Yasdanpanah Y, Descamps D, Peytavin G, Katlama C, Calvez V, Marcelin AG
HIV-1 diagnosis with unquantifiable viraemia: don't be naive, look for antiretroviral drugs.
The Journal of Antimicrobial Chemotherapy 2017, 72, 630-632.

Tubiana S, Blotière PO, Hoen B, Lesclous P, Millot S, Rudant J, Weill A, Coste J, Alla F, Duval X
Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study.
BMJ (Clinical research ed.) 2017, 358, j3776.

2016


Debray MP, Dauriat G, Khalil A, Leygnac S, Tubiana S, Grandjean A, Schouman-Claeys E, Laissy JP, Ou P
Diagnostic accuracy of low-mA chest CT reconstructed with Model Based Iterative Reconstruction in the detection of early pleuro-pulmonary complications following a lung transplantation.
European Radiology 2016, 26, 3138–3146.

Tubiana S, Duval X, Alla F, Selton-Suty C, Tattevin P, Delahaye F, Piroth L, Chirouze C, Lavigne JP, Erpelding ML, Hoen B, Vandenesch F, Iung B, Le Moing V, VSG
The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia.
The Journal of Infection 2016, 72, 544–553.

Katlama C, Soulié C, Caby F, Denis A, Blanc C, Schneider L, Valantin MA, Tubiana R, Kirstetter M, Valdenassi E, Nguyen T, Peytavin G, Calvez V, Marcelin AG
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2646–2650.

Hleyhel M, Goujon S, Delteil C, Vasiljevic A, Luzi S, Stephan JL, Reliquet V, Jannier S, Tubiana R, Dollfus C, Faye A, Mandelbrot L, Clavel J, Warszawski J, Blanche S, AFPCSG
Risk of cancer in children exposed to didanosine in utero.
AIDS (London, England) 2016, 30, 1245-1256.

2015


Iung B, Tubiana S, Alla F, Lavielle M
Infective endocarditis and antibiotic prophylaxis.
Lancet (London, England) 2015, 386, 529–530.

Maubec E, Laouénan C, Deschamps L, Nguyen VT, Scheer-Senyarich I, Wackenheim-Jacobs AC, Steff M, Duhamel S, Tubiana S, Brahimi N, Leclerc-Mercier S, Crickx B, Perret C, Aractingi S, Escoubet B, Duval X, Arnaud P, Jaisser F, Mentré F, Farman N
Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.
The Journal of Investigative Dermatology 2015, 135, 1781–1789.

Descamps D, Peytavin G, Visseaux B, Tubiana R, Damond F, Campa P, Charpentier C, Khuong-Josses MA, Duvivier C, Karmochkine M, Lukiana T, Matheron S
Dolutegravir in HIV-2 infected patients with resistant virus to first-line integrase inhibitors from the French Named Patient Program.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015

Tubiana S, Le Moing V, Duval X
Echocardiography in Patients With Enterococcal Bacteremia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 132.

Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S, FNAfRoAaVHFPCIMET
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 270-280.

Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S, AESG
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1715-1725.

Wirden M, Todesco E, Valantin MA, Lambert-Niclot S, Simon A, Calin R, Tubiana R, Peytavin G, Katlama C, Calvez V, Marcelin AG
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice.
The Journal of Antimicrobial Chemotherapy 2015

Tubiana S, Belchior E, Guillot S, Guiso N, Lévy-Bruhl D, RP
Monitoring the Impact of Vaccination on Pertussis in Infants Using an Active Hospital-based Pediatric Surveillance Network: Results from 17 Years' Experience, 1996-2012, France.
The Pediatric Infectious Disease Journal 2015, 34, 814–820.

Fauchet F, Treluyer JM, Illamola SM, Pressiat C, Lui G, Valade E, Mandelbrot L, Lechedanec J, Delmas S, Blanche S, Warszawski J, Urien S, Tubiana R, Hirt D
Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment.
Antimicrobial Agents and Chemotherapy 2015, 59, 5727-5735.

Lê MP, Mandelbrot L, Descamps D, Soulié C, Ichou H, Bourgeois-Moine A, Damond F, Lariven S, Valantin MA, Landman R, Faucher P, Tubiana R, Duro D, Meier F, Legac S, Bourse P, Mortier E, Dommergues M, Calvez V, Matheron S, Peytavin G
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.
Antiviral Therapy 2015, 20, 507-513.

2014


Mahr A, Batteux F, Tubiana S, Goulvestre C, Wolff M, Papo T, Vrtovsnik F, Klein I, Iung B, Duval X, ISG
Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis.
Arthritis & Rheumatology (Hoboken, N.J.) 2014, 66, 1672–1677.

Caby F, Schneider L, Blanc C, Soulié C, Tindel M, Peytavin G, Agher R, Valantin MA, Tubiana R, Wirden M, Calvez V, Marcelin AG, Katlama C
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.
Infection 2014, 42, 295–301.

Mandelbrot L, Berrebi A, Rouzioux C, Partisani M, Faucher P, Tubiana R, Matheron S, Bujan L, Morlat P, cPecmdpvaVcDdeg
[Reproductive options for people living with HIV: 2013 guidelines from the French expert working group].
Gynecologie, Obstetrique & Fertilite 2014, 42, 543-550.

Mandelbrot L, Berrébi A, Matheron S, Blanche S, Tubiana R, Rouzioux C, Faucher P, Partisani M, Boyer V, Taeron C, Faye A, Bujan L, Dabis F, Warszawski J, Morlat P
[HIV and pregnancy: 2013 guidelines from the French expert working group].
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2014, 43, 534-548.

Visseaux B, Charpentier C, Rouard C, Fagard C, Glohi D, Tubiana R, Damond F, Brun-Vézinet F, Matheron S, Descamps D, FH2ACC
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients.
AIDS (London, England) 2014, 28, 2160–2162.

Sibiude J, Mandelbrot L, Blanche S, Le Chenadec J, Boullag-Bonnet N, Faye A, Dollfus C, Tubiana R, Bonnet D, Lelong N, Khoshnood B, Warszawski J
Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11).
PLoS medicine 2014, 11, e1001635.

2013


Jasseron C, Mandelbrot L, Dollfus C, Trocmé N, Tubiana R, Teglas JP, Faye A, Rouzioux C, Blanche S, Warszawski J
Non-disclosure of a pregnant woman's HIV status to her partner is associated with non-optimal prevention of mother-to-child transmission.
AIDS and behavior 2013, 17, 488-497.

Blanche S, Dollfus C, Faye A, Rouzioux C, Mandelbrot L, Tubiana R, Warszawski J, CfAE
[Pediatric aids, 30 years later].
Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie 2013, 20, 890-896.

Briand N, Warszawski J, Mandelbrot L, Dollfus C, Pannier E, Cravello L, Nguyen R, Matheron I, Winer N, Tubiana R, Rouzioux C, Faye A, Blanche S, AECCSG
Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 903-914.

Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J, A1P(IMESG
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 891-902.

Todesco E, Sayon S, Fourati S, Tubiana R, Simon A, Ktorza N, Schneider L, Peytavin G, Malet I, Van den Eede P, Katlama C, Calvez V, Marcelin AG, Wirden M
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2882-2889.

Rachas A, Warszawski J, Le Chenadec J, Legeai C, Teglas JP, Goujard C, Rouzioux C, Mandelbrot L, Tubiana R, Meyer L
Does pregnancy affect the early response to cART?.
AIDS (London, England) 2013, 27, 357-367.

Descours B, Lambert-Niclot S, Mory B, Samri A, Charlotte F, Peytavin G, Tubiana R, Papagno L, Bacchus C, Lecardonnel F, Katlama C, Autran B, Marcelin AG, Valantin MA, Carcelain G, DaOSG
Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 62, 255-259.

Iung B, Tubiana S, Klein I, Messika-Zeitoun D, Brochet E, Lepage L, Al-Attar N, Ruimy R, Leport C, Wolff M, Duval X, EISG
Determinants of cerebral lesions in endocarditis on systematic cerebral magnetic resonance imaging: a prospective study.
Stroke 2013, 44, 3056–3062.

Tubiana S, Mikulski M, Becam J, Lacassin F, Lefèvre P, Gourinat AC, Goarant C, D'Ortenzio E
Risk factors and predictors of severe leptospirosis in New Caledonia.
PLoS neglected tropical diseases 2013, 7, e1991.

Tourdjman M, Le Hello S, Gossner C, Delmas G, Tubiana S, Fabre L, Kerléguer A, Tarantola A, Fruth A, Friesema I, Thorstensen Brandal L, Lawrence J, Fisher I, Dufour M, Weill FX, de Valk H
Unusual increase in reported cases of paratyphoid A fever among travellers returning from Cambodia, January to September 2013.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2013, 18,

2012


Sibiude J, Warszawski J, Tubiana R, Dollfus C, Faye A, Rouzioux C, Teglas JP, Ekoukou D, Blanche S, Mandelbrot L
Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1348-1360.

Clavel C, Peytavin G, Tubiana R, Soulié C, Courbon E, Crenn-Hebert C, Ichou H, Blanc C, Schneider L, Katlama C, Marcelin AG, Mandelbrot L
Etravirine concentrations in the cervicovaginal compartment in HIV-1-infected women receiving etravirine-containing antiretroviral therapy: DIVA 02 study.
Antimicrobial Agents and Chemotherapy 2012, 56, 4018-4020.

Calin R, Paris L, Simon A, Peytavin G, Wirden M, Schneider L, Valantin MA, Tubiana R, Agher R, Katlama C
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy.
Antiviral Therapy 2012, 17, 1601-1604.

2011


Briand N, Mandelbrot L, Blanche S, Tubiana R, Faye A, Dollfus C, Le Chenadec J, Benhammou V, Rouzioux C, Warszawski J, AFPC(EC0
Previous antiretroviral therapy for prevention of mother-to-child transmission of HIV does not hamper the initial response to PI-based multitherapy during subsequent pregnancy.
Journal of Acquired Immune Deficiency Syndromes (1999) 2011, 57, 126-135.

Charpentier C, Roquebert B, Delelis O, Larrouy L, Matheron S, Tubiana R, Karmochkine M, Duval X, Chêne G, Storto A, Collin G, Bénard A, Damond F, Mouscadet JF, Brun-Vézinet F, Descamps D, FAH2C(C0V2
Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir.
Antimicrobial Agents and Chemotherapy 2011, 55, 1293-1295.

Clavel C, Peytavin G, Tubiana R, Soulié C, Crenn-Hebert C, Heard I, Bissuel F, Ichou H, Ferreira C, Katlama C, Marcelin AG, Mandelbrot L
Raltegravir concentrations in the genital tract of HIV-1-infected women treated with a raltegravir-containing regimen (DIVA 01 study).
Antimicrobial Agents and Chemotherapy 2011, 55, 3018-3021.

2010


Tubiana R, Le Chenadec J, Rouzioux C, Mandelbrot L, Hamrene K, Dollfus C, Faye A, Delaugerre C, Blanche S, Warszawski J
Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2010, 50, 585-596.

2009


Mandelbrot L, Jasseron C, Ekoukou D, Batallan A, Bongain A, Pannier E, Blanche S, Tubiana R, Rouzioux C, Warszawski J, AFPC(
Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort.
American Journal of Obstetrics and Gynecology 2009, 200, 160.e1-9.

Guibert G, Warszawski J, Le Chenadec J, Blanche S, Benmebarek Y, Mandelbrot L, Tubiana R, Rouzioux C, Leruez-Ville M, FPC
Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2009, 48, 1516-1525.

Briand N, Mandelbrot L, Le Chenadec J, Tubiana R, Teglas JP, Faye A, Dollfus C, Rouzioux C, Blanche S, Warszawski J, AFPC
No relation between in-utero exposure to HAART and intrauterine growth retardation.
AIDS (London, England) 2009, 23, 1235-1243.

Delaugerre C, Chaix ML, Blanche S, Warszawski J, Cornet D, Dollfus C, Schneider V, Burgard M, Faye A, Mandelbrot L, Tubiana R, Rouzioux C, AFPC
Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome.
Retrovirology 2009, 6, 85.

2008


Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L, AFPC
Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
AIDS (London, England) 2008, 22, 289-299.

Jasseron C, Mandelbrot L, Tubiana R, Teglas JP, Faye A, Dollfus C, Le Chenadec J, Rouzioux C, Blanche S, Warszawski J, AFPC
Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?.
AIDS (London, England) 2008, 22, 1503-1511.

Benhammou V, Warszawski J, Bellec S, Doz F, André N, Lacour B, Levine M, Bavoux F, Tubiana R, Mandelbrot L, Clavel J, Blanche S, AEPF
Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.
AIDS (London, England) 2008, 22, 2165-2177.

2003


Legrand M, Comets E, Aymard G, Tubiana R, Katlama C, Diquet B
An in vivo pharmacokinetic/pharmacodynamic model for antiretroviral combination.
HIV clinical trials 2003, 4, 170-183.